Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Acquired by Perigon Wealth Management LLC

Perigon Wealth Management LLC increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,680 shares of the pharmacy operator’s stock after purchasing an additional 852 shares during the quarter. Perigon Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $305,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of WBA. Cerity Partners LLC raised its position in Walgreens Boots Alliance by 157.0% in the fourth quarter. Cerity Partners LLC now owns 356,014 shares of the pharmacy operator’s stock worth $9,296,000 after acquiring an additional 217,492 shares in the last quarter. Lynch Asset Management Inc. bought a new stake in Walgreens Boots Alliance in the fourth quarter worth about $261,000. Sequoia Financial Advisors LLC raised its position in Walgreens Boots Alliance by 1.8% in the fourth quarter. Sequoia Financial Advisors LLC now owns 165,726 shares of the pharmacy operator’s stock worth $4,327,000 after acquiring an additional 2,960 shares in the last quarter. Greylin Investment Management Inc raised its position in Walgreens Boots Alliance by 26.0% in the fourth quarter. Greylin Investment Management Inc now owns 425,226 shares of the pharmacy operator’s stock worth $11,103,000 after acquiring an additional 87,660 shares in the last quarter. Finally, Confluence Wealth Services Inc. bought a new stake in Walgreens Boots Alliance in the fourth quarter worth about $552,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. In the last quarter, insiders bought 13,456 shares of company stock valued at $270,423. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $17.64 on Wednesday. The business’s 50-day moving average is $20.70 and its 200-day moving average is $22.02. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.53 and a fifty-two week high of $36.14. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.16 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on WBA shares. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. UBS Group cut their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. SVB Leerink cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Finally, HSBC restated a “reduce” rating and set a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.